These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


425 related items for PubMed ID: 20969475

  • 1. Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities.
    Gambino R, Musso G, Cassader M.
    Antioxid Redox Signal; 2011 Sep 01; 15(5):1325-65. PubMed ID: 20969475
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of disease progression in nonalcoholic fatty liver disease.
    Jou J, Choi SS, Diehl AM.
    Semin Liver Dis; 2008 Nov 01; 28(4):370-9. PubMed ID: 18956293
    [Abstract] [Full Text] [Related]

  • 3. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis.
    Rolo AP, Teodoro JS, Palmeira CM.
    Free Radic Biol Med; 2012 Jan 01; 52(1):59-69. PubMed ID: 22064361
    [Abstract] [Full Text] [Related]

  • 4. Pathogenesis of nonalcoholic steatohepatitis (NASH).
    Ma X, Li Z.
    Chin J Dig Dis; 2006 Jan 01; 7(1):7-11. PubMed ID: 16412031
    [Abstract] [Full Text] [Related]

  • 5. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease.
    Nomura K, Yamanouchi T.
    J Nutr Biochem; 2012 Mar 01; 23(3):203-8. PubMed ID: 22129639
    [Abstract] [Full Text] [Related]

  • 6. Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis.
    Spahis S, Delvin E, Borys JM, Levy E.
    Antioxid Redox Signal; 2017 Apr 01; 26(10):519-541. PubMed ID: 27452109
    [Abstract] [Full Text] [Related]

  • 7. Fibrogenesis in nonalcoholic steatohepatitis.
    De Minicis S, Svegliati-Baroni G.
    Expert Rev Gastroenterol Hepatol; 2011 Apr 01; 5(2):179-87. PubMed ID: 21476913
    [Abstract] [Full Text] [Related]

  • 8. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH.
    Korean J Hepatol; 2008 Mar 01; 14(1):12-27. PubMed ID: 18367854
    [Abstract] [Full Text] [Related]

  • 9. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.
    Carter-Kent C, Zein NN, Feldstein AE.
    Am J Gastroenterol; 2008 Apr 01; 103(4):1036-42. PubMed ID: 18177455
    [Abstract] [Full Text] [Related]

  • 10. Fatty liver: role of inflammation and fatty acid nutrition.
    Byrne CD.
    Prostaglandins Leukot Essent Fatty Acids; 2010 Apr 01; 82(4-6):265-71. PubMed ID: 20189787
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC, Berk PD.
    Semin Liver Dis; 2008 Nov 01; 28(4):407-26. PubMed ID: 18956297
    [Abstract] [Full Text] [Related]

  • 13. Non-alcoholic fatty liver disease.
    Smith BW, Adams LA.
    Crit Rev Clin Lab Sci; 2011 Nov 01; 48(3):97-113. PubMed ID: 21875310
    [Abstract] [Full Text] [Related]

  • 14. Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role.
    Aubert J, Begriche K, Knockaert L, Robin MA, Fromenty B.
    Clin Res Hepatol Gastroenterol; 2011 Oct 01; 35(10):630-7. PubMed ID: 21664213
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inflammation in nonalcoholic steatohepatitis.
    Harmon RC, Tiniakos DG, Argo CK.
    Expert Rev Gastroenterol Hepatol; 2011 Apr 01; 5(2):189-200. PubMed ID: 21476914
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Metabolic disturbances in non-alcoholic fatty liver disease.
    Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH.
    Clin Sci (Lond); 2009 Apr 01; 116(7):539-64. PubMed ID: 19243311
    [Abstract] [Full Text] [Related]

  • 20. Non-alcoholic fatty liver disease.
    Leclercq I.
    Bull Mem Acad R Med Belg; 2010 Apr 01; 165(3-4):147-55; discussion 155-8. PubMed ID: 21166266
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.